Preventive cardiology is not separate from brain health
Recently, potent incretin mimetics, including semaglutide (a GLP1 receptor agonist) and tirzepatide (a dual GLP1 and GIP receptor agonist), have become widely available for patients with obesity or who have overweight and have a cardiovascular risk factor
Your monthly fee covers medication, 24/7 coaching access, provider messaging, community support, and free shippingno surprise costs as treatment progresses
The Search for GLP-1-Boosting Foods With the rise in popularity of GLP-1-based medications, more people are looking to their diets for ways to naturally enhance GLP-1 production
The root cause is systemic insulin resistance, typically driven by high calorie intake and positive energy balance (excess calories)
TFA Removal and Acetate Conversion A common byproduct of peptide synthesis is Trifluoroacetic Acid (TFA)